Organization · Venture Capital
Dimension
Dimension is a venture capital firm that invests in early-stage companies at the intersection of technology and life sciences, with offices in New York and San Francisco.
Overview
What Dimension does
What Dimension is
Dimension is a venture capital firm that invests in early-stage companies at the intersection of technology and life sciences, with offices in New York and San Francisco.
How it participates in the startup ecosystem
The current public profile supports funder and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder · Event host · Publisher
- Last reviewed
- March 27, 2026
Official channels
Find Dimension elsewhere
Open the official website or a supported primary organization account.
Capability profile
Dimension as a funder
Investment thesis
Dimension targets the intersection of technology and life sciences, focusing on companies where computational tools, AI, and biology converge to transform drug development.
Focus narrative
Dimension invests in companies at the intersection of technology and life sciences, specifically in sectors such as biotech platforms, software infrastructure, lab tools and instruments, clinical development, manufacturing and commercialization, and machine learning and artificial intelligence. The firm is flexible in its investment approach, targeting various stages of company development.
Value beyond capital
Dimension adds value to its portfolio companies by providing insights and updates through various channels, including a blog, newsletters, and podcasts. The firm also hosts events and discussions to engage with the community and share insights on the intersection of technology and life sciences.
Focus and fit
- Stages
- Friends and Family · Seed · Series A · Series B · Growth Equity
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Notable portfolio companies include: Chai Discovery: Engineering better molecules using artificial intelligence. Modal Labs: Provides high-performance AI infrastructure. Enveda Biosciences: Focuses on unlocking the planet's chemistry to discover next-generation therapies. Achira: Develops foundation simulation models for drug discovery. Aspect Biosystems: Works on building a new class of regenerative medicines. Automata: Specializes in next-generation lab automation and data management. Kimia Therapeutics: Develops a drug discovery engine using Chemotype Evolution. Lamin: Provides open-source software infrastructure for modern labs. Monte Rosa Therapeutics: Focuses on geometric deep learning for rational design of next-generation protein degrader therapeutics. NewLimit: Aims to treat age-related diseases to extend human healthspan. Stately Bio: Develops an ML-powered cellular imaging platform for regenerative medicine.
Capability profile
Dimension as an event host
Event focus
Dimension focuses on investing in companies that operate at the intersection of technology and life sciences. Their investment strategy encompasses various sectors, including biotech platforms, software infrastructure, lab tools and instruments, clinical development, manufacturing and commercialization, as well as machine learning and artificial intelligence. The firm is adaptable in its approach, targeting a range of stages in company development.
Format narrative
Dimension hosts various events and discussions to engage with the community and share insights on the intersection of technology and life sciences.
Participant value
Dimension aims to partner with entrepreneurs to transform the trajectory of life on earth through innovative solutions in biotech and technology. Their investments are designed to support groundbreaking advancements in life sciences and technology.
Format and cadence
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Stages
- Pre-seed · Seed · Series A · Growth Equity
- Audience
- Founders · Investors
- Regions
- North America
Capability profile
Dimension as a publisher
Editorial focus
Dimension is a venture capital firm that partners with entrepreneurs at the intersection of technology and life sciences. The firm focuses on innovative investments that aim to catalyze the potential between computing and biology, targeting various stages of company development.
Audience value
Dimension offers a founder-centric partnership model, providing flexible investment approaches that emphasize fundamental research in science and technology, aimed at transforming drug development and improving lives.
Format and cadence
- Content formats
- blog, newsletter, and podcast
- Primary platform
- dimensioncap.com
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Founders · Investors
- Regions
- Global · United States
Flagship work and coverage
Flagship properties
Dimension publishes insights through a blog, newsletters, and podcasts, engaging with industry leaders and discussing relevant topics in technology and life sciences.
Notable coverage
Dimension has been featured in notable publications such as TechCrunch, FierceBiotech, BioPharma Dive, and STAT News, highlighting its rapid fund scaling and innovative investment approach.
Common questions
What to know about Dimension
Upseed classifies Dimension under the Venture Capital organization type. Its current public profile includes funder, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.